Trial ID or NCT#

NCT00383604

Status

NOT RECRUITING

Purpose

To better understand the mechanisms leading to lymphedema development in breast cancer survivors, and the implications for potential innovative approaches to the screening, prevention and treatment of this condition.

Official Title

Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No

Investigator(s)

Stanley G. Rockson, MD
Cardiologist
Allan and Tina Neill Professor of Lymphatic Research and Medicine

Contact us to find out if this trial is right for you.

CONTACT

Anne Marie Vaillant-Newman
(650) 498-4460